CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells.

Li, Guangchao; Guo, Jintao; Zheng, Yanfang; Ding, Wen; Han, Zheping; Qin, Lingyu; Mo, Wenjun; Luo, Min

CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells.

Li, Guangchao; Guo, Jintao; Zheng, Yanfang; Ding, Wen; Han, Zheping; Qin, Lingyu; Mo, Wenjun; Luo, Min.

Affiliation

Li G; Guangzhou Bio-gene Technology Co., Ltd., Guangzhou, Guangdong Province, China.
Guo J; Guangzhou Bio-gene Technology Co., Ltd., Guangzhou, Guangdong Province, China.
Zheng Y; Department of Oncology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
Ding W; Guangzhou Bio-gene Technology Co., Ltd., Guangzhou, Guangdong Province, China.
Han Z; Department of Laboratory Medicine, Central Hospital of Panyu District, Guangzhou, Guangdong Province, China.
Qin L; Department of Oncology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
Mo W; Guangzhou Bio-gene Technology Co., Ltd., Guangzhou, Guangdong Province, China.
Luo M; Guangzhou Bio-gene Technology Co., Ltd., Guangzhou, Guangdong Province, China.

Mol Ther Oncolytics ; 22: 507-517, 2021 Sep 24.

Article de En | MEDLINE | ID: mdl-34553036

Mots clés

CAR-T cells; CXCL13; CXCR5; chemokine; immunotherapy; lung cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Mol Ther Oncolytics Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google